Related Experiment Video
Updated: Apr 1, 2026

09:57
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
Published on: June 28, 2021
2.5K
Therapeutic potential of interleukin-27 against cancers in preclinical mouse models
Izuru Mizoguchi1, Yukino Chiba1, Jun-Ichi Furusawa1
1Department of Immunoregulation; Institute of Medical Science; Tokyo Medical University ; Tokyo, Japan.
Oncoimmunology
|October 10, 2015
Abstract:
Since we first reported the antitumor efficacy of IL-27 in 2004, accumulating evidence obtained by several groups using a variety of preclinical mouse models indicates that IL-27 possesses potent antitumor activity against various types of tumors through multiple mechanisms depending on the characteristics of individual tumors without apparent adverse effects.
More Related Videos
Related Concept Videos
Mouse Models of Cancer Study
6.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.7K
Mouse Models of Cancer Study
2.5K
2.5K

